Clinical Trial Update: A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update describes evaluating safety, tolerability, efficacy, and pharmacokinetics of LT-002-158 tablets in Chinese adults with atopic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LT-002-158 tablets (LT-002-158)

Snippet

Sponsor: Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | Conditions: Atopic Dermatitis (AD) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING